Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

T1Covered by 1 source · first reported by Ars Technica at 22 Oct, 22:12 UTC

Markers released top-line results today after previously reporting the trial succeeded.

releases

Sources

• T1Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%Ars Technica22 Oct, 22:12